Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company is headquartered in Waltham, Massachusetts. Show more

Location: 300 Fifth Avenue, Waltham, MA, 02451, United States | Website: https://crescentbiopharma.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

214.6M

52 Wk Range

$9.81 - $63.00

Previous Close

$12.79

Open

$12.95

Volume

9,210

Day Range

$12.52 - $13.20

Enterprise Value

54.89M

Cash

152.6M

Avg Qtr Burn

-6.269M

Insider Ownership

10.37%

Institutional Own.

82.11%

Qtr Updated

06/30/25